The novel fibrosis index at diagnosis may predict all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis without substantial liver diseases
CONCLUSIONS: NFI ≥ 1.24, which may be an independent predictive marker for all-cause mortality in AAV patients without substantial liver disease.
Source: Clinics - Category: General Medicine Source Type: research
More News: Bilirubin | General Medicine | Laboratory Medicine | Liver | Liver Disease | Statistics | Study | Urology & Nephrology | Vasculitis